These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5064 related articles for article (PubMed ID: 18249324)

  • 1. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
    Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of aprotinin on postoperative renal dysfunction in neonates undergoing cardiopulmonary bypass: a retrospective analysis.
    Guzzetta NA; Evans FM; Rosenberg ES; Fazlollah TM; Baker MJ; Wilson EC; Kaiser AM; Tosone SR; Miller BE
    Anesth Analg; 2009 Feb; 108(2):448-55. PubMed ID: 19151271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of tranexamic acid compared with aprotinin in thoracic aortic surgery with deep hypothermic circulatory arrest.
    Nicolau-Raducu R; Subramaniam K; Marquez J; Wells C; Hilmi I; Sullivan E
    J Cardiothorac Vasc Anesth; 2010 Feb; 24(1):73-9. PubMed ID: 19717314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of renal dysfunction and the use of aprotinin in patients undergoing congenital cardiac surgery requiring cardiopulmonary bypass.
    Manrique A; Jooste EH; Kuch BA; Lichtenstein SE; Morell V; Munoz R; Ellis D; Davis PJ
    Anesth Analg; 2009 Jul; 109(1):45-52. PubMed ID: 19535694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal dysfunction in cardiac surgery: identifying potential risk factors.
    Barnum JL; Sistino JJ
    Perfusion; 2009 Mar; 24(2):139-42. PubMed ID: 19654159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the effect of aprotinin and ε-aminocaproic acid on renal function in children undergoing cardiac surgery.
    Leyvi G; Nelson O; Yedlin A; Pasamba M; Belamarich PF; Nair S; Cohen HW
    J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):402-6. PubMed ID: 21419653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery?
    Kincaid EH; Ashburn DA; Hoyle JR; Reichert MG; Hammon JW; Kon ND
    Ann Thorac Surg; 2005 Oct; 80(4):1388-93; discussion 1393. PubMed ID: 16181876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seizures after open heart surgery: comparison of ε-aminocaproic acid and tranexamic acid.
    Martin K; Knorr J; Breuer T; Gertler R; Macguill M; Lange R; Tassani P; Wiesner G
    J Cardiothorac Vasc Anesth; 2011 Feb; 25(1):20-5. PubMed ID: 21272777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial.
    Mahesh B; Yim B; Robson D; Pillai R; Ratnatunga C; Pigott D
    Eur J Cardiothorac Surg; 2008 Mar; 33(3):370-6. PubMed ID: 18243724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased incidence of acute kidney injury with aprotinin use during cardiac surgery detected with urinary NGAL.
    Wagener G; Gubitosa G; Wang S; Borregaard N; Kim M; Lee HT
    Am J Nephrol; 2008; 28(4):576-82. PubMed ID: 18264006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aprotinin in cardiac surgery patients: is the risk worth the benefit?
    Stamou SC; Reames MK; Skipper E; Stiegel RM; Nussbaum M; Geller R; Robicsek F; Lobdell KW
    Eur J Cardiothorac Surg; 2009 Nov; 36(5):869-75. PubMed ID: 19782574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery.
    Karkouti K; Beattie WS; Dattilo KM; McCluskey SA; Ghannam M; Hamdy A; Wijeysundera DN; Fedorko L; Yau TM
    Transfusion; 2006 Mar; 46(3):327-38. PubMed ID: 16533273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated creatinine clearance instead of plasma creatinine level as prognostic test for postoperative renal function in patients undergoing coronary artery bypass surgery.
    Noyez L; Plesiewicz I; Verheugt FW
    Eur J Cardiothorac Surg; 2006 Apr; 29(4):461-5. PubMed ID: 16483789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of aprotinin on outcome after coronary-artery bypass grafting.
    Shaw AD; Stafford-Smith M; White WD; Phillips-Bute B; Swaminathan M; Milano C; Welsby IJ; Aronson S; Mathew JP; Peterson ED; Newman MF
    N Engl J Med; 2008 Feb; 358(8):784-93. PubMed ID: 18287601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients.
    Martin K; Wiesner G; Breuer T; Lange R; Tassani P
    Anesth Analg; 2008 Dec; 107(6):1783-90. PubMed ID: 19020118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aprotinin in primary cardiac surgery: operative outcome of propensity score-matched study.
    Ngaage DL; Cale AR; Cowen ME; Griffin S; Guvendik L
    Ann Thorac Surg; 2008 Oct; 86(4):1195-202. PubMed ID: 18805159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
    Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary artery bypass grafting in non-dialysis-dependent mild-to-moderate renal dysfunction.
    Weerasinghe A; Hornick P; Smith P; Taylor K; Ratnatunga C
    J Thorac Cardiovasc Surg; 2001 Jun; 121(6):1083-9. PubMed ID: 11385375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aprotinin use in cardiac surgery patients at low risk for requiring blood transfusion.
    Kristeller JL; Stahl RF; Roslund BP; Roke-Thomas M
    Pharmacotherapy; 2007 Jul; 27(7):988-94. PubMed ID: 17594204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 254.